Long-term tremor therapy for Parkinson and essential tremor with sensor-guided botulinum toxin type A injections

OBJECTIVE: Current pharmacological agents used to treat Parkinson disease (PD) tremor and essential tremor (ET) provide suboptimal benefit and are commonly associated with significant adverse effects. Botulinum toxin type A (BoNT-A) has been shown to be effective for wrist tremor though functionally...

Descripción completa

Detalles Bibliográficos
Autores principales: Samotus, Olivia, Lee, Jack, Jog, Mandar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460844/
https://www.ncbi.nlm.nih.gov/pubmed/28586370
http://dx.doi.org/10.1371/journal.pone.0178670

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460844/
https://www.ncbi.nlm.nih.gov/pubmed/28586370
http://dx.doi.org/10.1371/journal.pone.0178670

Ejemplares similares